|
VAMP7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.44266845534003E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.86406445834564E-13 |
| Normal-vs-Stage2 |
2.678500E-03 |
| Normal-vs-Stage3 |
4.541800E-01 |
| Normal-vs-Stage4 |
1.236210E-03 |
| Stage1-vs-Stage2 |
2.848200E-01 |
| Stage1-vs-Stage3 |
8.137900E-02 |
| Stage1-vs-Stage4 |
7.080400E-01 |
| Stage2-vs-Stage3 |
2.880800E-01 |
| Stage2-vs-Stage4 |
3.386600E-01 |
| Stage3-vs-Stage4 |
8.404300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.81143988697841E-12 |
| Normal-vs-AfricanAmerican |
6.09440000000072E-05 |
| Normal-vs-Asian |
9.870200E-01 |
| Caucasian-vs-AfricanAmerican |
7.605900E-02 |
| Caucasian-vs-Asian |
3.424000E-01 |
| AfricanAmerican-vs-Asian |
4.911600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.65223390524716E-12 |
| Normal-vs-Female |
8.221100E-04 |
| Male-vs-Female |
3.577000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.33039999519846E-08 |
| Normal-vs-Extreme_Weight |
1.62836411021772E-12 |
| Normal-vs-Obese |
6.02959999707053E-08 |
| Normal-vs-Extreme_Obese |
1.550090E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.913400E-01 |
| Normal_Weight-vs-Obese |
2.828000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.517800E-01 |
| Extreme_Weight-vs-Obese |
1.519830E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.623400E-01 |
| Obese-vs-Extreme_Obese |
7.653000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.290000E-02 |
| Normal-vs-Age(41-60Yrs) |
9.3673957479723E-11 |
| Normal-vs-Age(61-80Yrs) |
5.70250513476367E-11 |
| Normal-vs-Age(81-100Yrs) |
1.98429999986871E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.141030E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.344830E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.021800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.746200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.631800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.195200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62558855265615E-12 |
| Normal-VS-Type2 PRCC |
4.801400E-03 |
| Normal-VS-KIRP CIMP |
3.111400E-01 |
| Normal-VS-Unclassified PRCC |
6.226000E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.519750E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.859900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.556700E-03 |
| Type2 PRCC-VS-KIRP CIMP |
6.140800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.475400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.607200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.8540999999952E-05 |
| Normal-vs-N1 |
3.851400E-01 |
| Normal-vs-N2 |
1.271150E-01 |
| N0-vs-N1 |
3.420400E-01 |
| N0-vs-N2 |
7.885600E-01 |
| N1-vs-N2 |
5.666200E-01 |
|
|
